These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 26202612)

  • 1. The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.
    Hvoslef-Eide M; Mar AC; Nilsson SR; Alsiö J; Heath CJ; Saksida LM; Robbins TW; Bussey TJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3853-72. PubMed ID: 26202612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-dependent effects on acquisition and reversal of visual and spatial tasks in a rat touchscreen battery of cognition.
    Kumar G; Talpos J; Steckler T
    Physiol Behav; 2015 May; 144():26-36. PubMed ID: 25744936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel 2- and 3-choice touchscreen-based continuous trial-unique nonmatching-to-location task (cTUNL) sensitive to functional differences between dentate gyrus and CA3 subregions of the hippocampus.
    Oomen CA; Hvoslef-Eide M; Kofink D; Preusser F; Mar AC; Saksida LM; Bussey TJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3921-3933. PubMed ID: 26220610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.
    Barak S; Weiner I
    Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test.
    Ding Z; Brown JW; Rueter LE; Mohler EG
    Psychopharmacology (Berl); 2018 Apr; 235(4):1093-1105. PubMed ID: 29332255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.
    Carter CS; Barch DM
    Schizophr Bull; 2007 Sep; 33(5):1131-7. PubMed ID: 17630405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats.
    Bussey TJ; Holmes A; Lyon L; Mar AC; McAllister KA; Nithianantharajah J; Oomen CA; Saksida LM
    Neuropharmacology; 2012 Mar; 62(3):1191-203. PubMed ID: 21530550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
    Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cognitive functions in animal models of schizophrenia.
    Nikiforuk A
    Pharmacol Rep; 2018 Aug; 70(4):639-649. PubMed ID: 29894866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats.
    Ko T; Evenden J
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):67-78. PubMed ID: 18825373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine.
    Stip E; Remington GJ; Dursun SM; Reiss JP; Rotstein E; MacEwan GW; Chokka PR; Jones B; Dickson RA;
    J Clin Psychopharmacol; 2003 Aug; 23(4):400-4. PubMed ID: 12920417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment.
    Talpos JC; Aerts N; Fellini L; Steckler T
    Pharmacol Biochem Behav; 2014 Jul; 122():97-106. PubMed ID: 24662914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Translation Using the Rodent Touchscreen Testing Approach.
    Hvoslef-Eide M; Nilsson SR; Saksida LM; Bussey TJ
    Curr Top Behav Neurosci; 2016; 28():423-47. PubMed ID: 27305921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.
    Cadinu D; Grayson B; Podda G; Harte MK; Doostdar N; Neill JC
    Neuropharmacology; 2018 Nov; 142():41-62. PubMed ID: 29196183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.
    Young JW; Powell SB; Risbrough V; Marston HM; Geyer MA
    Pharmacol Ther; 2009 May; 122(2):150-202. PubMed ID: 19269307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs.
    Mar AC; Nilsson SRO; Gamallo-Lana B; Lei M; Dourado T; Alsiö J; Saksida LM; Bussey TJ; Robbins TW
    Psychopharmacology (Berl); 2017 Oct; 234(19):2837-2857. PubMed ID: 28744563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of D- and L-govadine on the disruption of touchscreen object-location paired associates learning in rats by acute MK-801 treatment.
    Lins BR; Phillips AG; Howland JG
    Psychopharmacology (Berl); 2015 Dec; 232(23):4371-82. PubMed ID: 26359226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.